Pilot Testing a Web-based Prototype of a Lung Cancer Screening Digital Health Tool

NCT07716527 | Enrolling By Invitation

• 1 other identifier: Pro2026000388
• Study Type: interventional
• Target: 500
• Locations: 1 country
• Sites: 1

Brief Summary

The purpose of this study is to evaluate the acceptability, usability, and preliminary efficacy of a web-based prototype of a digital health tool for lung cancer screening (LCS). The digital health tool is designed to support high quality decision-making for individuals potentially eligible for lung cancer screening. Researchers will compare the intervention arm (who will use the digital health tool prototype) with the control arm (who will read a 2-page publicly available information sheet about lung cancer screening from American Cancer Society).

Conditions

Lung Cancer Screening

Keywords

Lung cancer screening; Digital health tool; Web-based prototype; Prototype; Decision support

Outcome Measures

Primary Outcomes (1)

• Self- reported receipt of Lung Cancer Screening

  Self-reported receipt of LCS within 3 months of exposure to the digital health tool

  3 months

Secondary Outcomes (10)

• Lung Cancer Screening Intention

  Immediately post-intervention (within 24 hours)

• Stage of Decision Making

  Immediately post-intervention (within 24 hours)

• Ottowa Acceptability Measure

  Immediately post-intervention (within 24 hours)

• System Usability Scale (SUS)

  Immediately post-intervention (within 24 hours)

• Knowledge of LCS

  Immediately post-intervention (within 24 hours)

Study Arms (2)

Intervention

EXPERIMENTAL

Behavioral: Digital health tool prototype

Control

ACTIVE COMPARATOR

Behavioral: Control Arm - standard of care

Interventions

Digital health tool prototype BEHAVIORAL

Intervention participants will view a web-based interactive prototype of the digital health tool. The digital health tool contains information about lung cancer screening, the screening procedures, a personalized lung cancer risk calculator, patient stories, frequently asked questions, and smoking cessation resources.

Intervention

Control Arm - standard of care BEHAVIORAL

The control arm will read a 2-page educational material about lung cancer screening publicly available from American Cancer Society.

Control

Eligibility Criteria

• Age: 50 Years - 80 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Age 50-80 years
• Currently smoke or have quit smoking within the past 15 years
• English-speaking

You may not qualify if:

• Younger than 50 years or older than 80 years
• Never smoked or quit smoking more than 50 years ago
• Non-English-speaking

Sponsors & Collaborators

• Rutgers, The State University of New Jersey: lead

Study Sites (1)

Rutgers Cancer Institute of New Jersey

New Brunswick, New Jersey, 08901, United States

Location

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: PARTICIPANT
• Purpose: PREVENTION
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Instructor of Medicine

Study Record Dates

• First Submitted: June 30, 2026
• First Posted: July 21, 2026
• Study Start: June 1, 2026
• Primary Completion (Estimated): October 15, 2026
• Study Completion (Estimated): October 15, 2026
• Last Updated: July 21, 2026

Record last verified: 2026-07

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)